JNJ vs IDXX
By Alex · Tickerpine
Johnson & Johnson vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | IDXX |
|---|---|---|
| Price | $263.81 | $560.38 |
| Market cap | $635.07B | $44.15B |
| P/E ratio | 40.0 | 39.4 |
| ROE | 20.02% | 74.21% |
| Profit margin | 16.20% | 25.03% |
| Revenue growth | 5.90% | 9.70% |
| Dividend yield | 2.03% | 0.00% |
| Beta | 0.21 | 1.55 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs IDXX in plain English
- JNJ is the bigger company — about 14.4× the market cap of IDXX.
- IDXX is cheaper on earnings (P/E 39.4 vs 40.0).
- IDXX earns a higher return on equity (74% vs 20%).
- IDXX is growing revenue faster (10% vs 6%).
- JNJ pays a dividend (2.03%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.